You are here: Home > Investor Relations

 Investor Relations

 
 Recent Releases

 Archived Releases

 Annual Meeting

 Analyst Coverage

 Corporate Governance

 SEC Filings

 XBRL Interactive Data
 Files


 Transfer Agent

 Auditors

 E-Mail Alerts
 
 Contact Us

10/24/2014 ELITE PHARMACEUTICALS ANNOUNCES NEW MANAGEMENT APPOINTMENTS

9/9/2014 ELITE PHARMACEUTICALS RELEASES POSITIVE TOP LINE HUMAN ABUSE LIABILITY DATA FOR ELI-200, AN OPIOID ABUSE DETERRENT PRODUCT
HAL study compared subjective effects of drug liking, drug high and good drug effects between ELI-200 and the comparator formulation in non-dependent recreational drug users


9/3/2014 ELITE PHARMACEUTICALS TO PRESENT AT THE 16TH ANNUAL RODMAN & RENSHAW GLOBAL INVESTMENT CONFERENCE IN NEW YORK CITY SEPTEMBER 8-10TH

8/14/2014 Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2015 Revenues Increase by 61%, Product Development on Schedule Conference Call Scheduled for Monday, August 18th at 11:00 AM EDT

8/13/2014 Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on August 18, 2014 .First Quarter Financials for Fiscal Year 2015 Are Scheduled To Be Filed on Thursday, August 14, 2014

More Releases...

Click Here for a complete archive


Elite Pharmaceuticals, Inc. 165 Ludlow Ave., Northvale, NJ 07647    Phone:  201-750-2646  Fax:  201-750-2755 
E Mail:  webmaster@elitepharma.com